Evidence map›Paper›PMID 36110194›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Hoai Thi Thu Tran, Philipp Peterburs, Jan Seibel, D Abramov-Sommariva, Evelyn Lamy

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

  • Commented on by
    2023
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hoai Thi Thu TranMolecular Preventive Medicine, University of Freiburg, Medical Center and Faculty of Medicine, Engesserstraße 4, 79108 Freiburg, Germany.ORCID https://orcid.org/0000-0001-5736-898X
Philipp PeterbursBionorica SE, Kerschensteinerstraße 11-15, 92318 Neumarkt, Germany.ORCID https://orcid.org/0000-0002-5149-9986
Jan SeibelBionorica SE, Kerschensteinerstraße 11-15, 92318 Neumarkt, Germany.ORCID https://orcid.org/0000-0002-0711-0478
D Abramov-SommarivaBionorica SE, Kerschensteinerstraße 11-15, 92318 Neumarkt, Germany.ORCID https://orcid.org/0000-0002-8293-9403
Evelyn LamyMolecular Preventive Medicine, University of Freiburg, Medical Center and Faculty of Medicine, Engesserstraße 4, 79108 Freiburg, Germany.ORCID https://orcid.org/0000-0002-5620-1595
Bionorica (Germany) · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 herbal medicinal products may have the potential for symptom relief in nonsevere or moderate disease cases. In this

Identifiers

PMID36110194
PMCPMC9470301
OpenAlexW4294795641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.